Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults

Autor: Jackson, Lisa A., Stapleton, Jack T., Walter, Emmanuel B., Chen, Wilbur H., Rouphael, Nadine G., Anderson, Evan J., Neuzil, Kathleen M., Winokur, Patricia L., Smith, Michael J., Schmader, Kenneth E., Swamy, Geeta K., Thompson, Amelia B., Mulligan, Mark J., Rostad, Christina A., Cross, Kaitlyn, Tsong, Rachel, Wegel, Ashley, Roberts, Paul C.

Publikováno v: In Vaccine 12 January 2024 42(2):295-309

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial.

Autor: Sahly, Hana M El, Yildirim, Inci, Frey, Sharon E, Winokur, Patricia, Jackson, Lisa A, Bernstein, David I, Creech, C Buddy, Chen, Wilbur H, Rupp, Richard E, Whitaker, Jennifer A, Phadke, Varun, Hoft, Daniel F, Ince, Dilek, Brady, Rebecca C, Edwards, Kathryn M, Ortiz, Justin R, Berman, Megan A, Weiss, Julia, Wegel, Ashley, Group, DMID 17-0090 Study

Publikováno v: Journal of Infectious Diseases; 2/15/2024, Vol. 229 Issue 2, p327-340, 14p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody Responses.

Autor: Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland, Baltimore, MD, USA., Anderson EJ; Departments of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, GA, USA., Frenck RW; Cincinnati Children's Hospital, Cincinnati, OH, USA., Frey SE; Center for Vaccine Development, Saint Louis University, St. Louis, MO, USA., Walter EB; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Rupp R; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA., Rotrosen ET; Center for Vaccine Development and Global Health, University of Maryland, Baltimore, MD, USA., Rouphael NG; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA., Brady RC; Cincinnati Children's Hospital, Cincinnati, OH, USA., Graham I; Center for Vaccine Development, Saint Louis University, St. Louis, MO, USA., Schmader KE; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Porterfield L; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, TX, USA., Ortiz JR; Center for Vaccine Development and Global Health, University of Maryland, Baltimore, MD, USA., Swamy GK; Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, NC, USA., El Sahly HM; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA., Jeevan T; St. Jude Children's Research Hospital, Memphis, TN, USA., Sitaula R; The Emmes Company, Rockville, MD, USA., Wegel A; The Emmes Company, Rockville, MD, USA., Webby RJ; St. Jude Children's Research Hospital, Memphis, TN, USA., Bryant C; The Emmes Company, Rockville, MD, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Jan 05. Date of Electronic Publication: 2023 Jan 05.